LOGC Market Cap History



Below is a table of the LOGC market cap history going back to 10/19/2018:

Date LOGC Market Cap
10/19/2018238.14M
11/30/2018348.61M
3/31/2019220.81M
5/10/2019312.67M
8/8/2019236.20M
11/7/2019226.26M
3/10/2020173.82M
5/7/2020171.63M
6/3/2020179.27M
8/6/2020187.24M
11/5/2020193.90M
3/9/2021257.49M
5/5/2021164.66M
7/30/2021134.44M
11/8/2021125.57M
2/25/202223.73M
5/10/202215.16M
8/9/202219.12M
11/8/202268.23M

Also see: LOGC Shares Outstanding History
and LOGC YTD Return
LOGC Historical Market Cap:
-26.51% CAGR
LOGC Historical Market Cap: +-26.51% CAGR

Mouse over chart for data details
10/19/2018 ...11/8/2022
LogicBio Therapeutics is a clinical-stage genetic medicine company focused on genome editing and gene delivery platforms to address diseases from infancy through adulthood. Co.'s genome editing platform, GeneRide™, is an approach to gene insertion harnessing a cell's natural deoxyribonucleic acid repair process. Co.'s product candidate, LB-001, is a single-administration, genome editing therapy developed using its GeneRide technology for the treatment of methylmalonic acidemia in pediatric patients. Co.'s other product candidate, LB-401 is based on its GeneRide technology. LB-401 is a genome editing therapy being developed for the treatment of hereditary tyrosinemia type 1 in newborns. We show 19 historical shares outstanding datapoints in our LOGC shares outstanding history coverage, used to compute LOGC market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LOGC market cap history over the course of time is important for investors interested in comparing LOGC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LOGC versus a peer is one thing; comparing LOGC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LOGC can fluctuate over the course of history. With this page we aim to empower investors researching LOGC by allowing them to research the LOGC market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree LOGC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
LogicBio Therapeutics (LOGC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

LOXO Market Cap History
LPCN Market Cap History
LPNT Market Cap History
LPTX Market Cap History
LQDA Market Cap History
LRMR Market Cap History
LTRN Market Cap History
LUCD Market Cap History
LUMO Market Cap History
LUNG Market Cap History
More Healthcare companies »

 

LOGC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.